Kimberley · Sandton · Schweizer Reneke · nationwide telemedicine +27 61 167 0260  |  info@swissmedica.co.za

Injectable peptide · prescription-only

B-NAD+ pen

NAD+ precursor therapy in a reusable pen. Cellular energy and metabolism.

Swiss Medica B-NAD+ pen
Prescription required

R2,999

100mg/ml, 3ml reusable pen · Subcutaneous injection · no separate script fee

What it is

NAD+ precursor therapy in a reusable pen. Cellular energy and metabolism.

How it is supplied

Supplied as 100mg/ml, 3ml reusable pen, for subcutaneous injection. Every preparation is compounded for you by name, on prescription, by a SAHPRA-licensed South African compounding pharmacy — not imported research-grade material bought online.

Form100mg/ml, 3ml reusable pen
RouteSubcutaneous injection
PrescriptionRequired
PriceR2,999

This is a compounded preparation, not a SAHPRA-registered medicine. It is prepared for a named patient against a valid prescription and is supplied only after a consultation. Nothing here is medical advice or an offer to supply a prescription medicine without a prescription.

Common questions

Do I need a prescription for B-NAD+ pen?

Yes. B-NAD+ pen is a compounded, prescription-only preparation. It is dispensed only against a valid Swiss Medica prescription written for you by name, which follows a consultation.

Is B-NAD+ pen a registered medicine?

No. It is compounded for an individual patient by a SAHPRA-licensed South African pharmacy and is not a SAHPRA-registered medicine. Your doctor will explain the evidence, and its limits, before prescribing.